CLINICAL ROLE -
Financial Incentives Improve Blood Glucose Control Among Type 1 Diabetes Patients
Financial rewards may be an effective way to get young patients with diabetes to achieve blood glucose targets.
Read More
Trending News Today: Individual Mandate Repeal Would Increase the Uninsured Rate
Top news of the day from across the healthcare landscape.
Trending News Today: Child Receives Life-Saving Genetically Engineered Skin Transplant
CMS Takes Steps to Reform Medicaid
New policies can help increase flexibility to improve Medicaid.
Phase 3 Data Suggest Humira Biosimilar Safe, Effective
Adalimumab-adbm (Cyltezo) showed equivalent safety and immunogenicity to adalimumab (Humira).
Diabetic Retinopathy Driven by VEGF-Related Protein
Inhibiting a protein may reduce symptoms of diabetic retinopathy.
Direct-Acting Antivirals Slash the Risk of HCV-Associated Liver Cancer
Patients without cirrhosis who achieved a sustained virological response had the lowest risk of hepatocellular carcinoma linked to hepatitis C virus.
AbbVie Partners to Develop Immune Drug for Alzheimer's disease
Growing evidence suggests immune deficiencies in the central nervous system are involved with Alzheimer’s disease.
Trending News Today: Maine Voters Approve Medicaid Expansion
Trending News Today: Top Oncology Group Warns About Alcohol-Cancer Link
Future of Biosimilars Uncertain
Biosimilars have yet to make a significant impact on the prescription drug market.
FDA Update for Rheumatic Disease Drugs Presented at ACR Conference
FDA officials discuss safety data and drug approvals at the American College of Rheumatology Annual Meeting.
Rheumatologists Should Start Screening for Heart Disease
A significant portion of patients with rheumatoid arthritis may develop cardiovascular disease.
CMS Finalizes Physician Fee Schedule, Quality Payment Program Rules
Changes to the rules are expected to reduce physician burden and foster innovation in healthcare.
Immunotherapy May Increase Prevalence of Autoimmune Rheumatic Conditions
With the growing use of cancer immunotherapies, rheumatologists expect to see more cases of inflammatory conditions.
Liver Cirrhosis Presents Higher Mortality Rate Than Cancer
Mortality related to liver cirrhosis outpaces the rate for lung, colorectal, stomach, liver, and breast cancers.
Osteoarthritis Phenotypes May Lead to Better Treatment Options
Patients with osteoarthritis may be able to receive targeted therapy based on phenotypes.
Parkinson's Disease Gene Required for Healthy Dopamine Neurons
New findings may result in a better treatment against Parkinson’s disease.
Trending News Today: ACA Sign Ups Hit Record High
Trending News Today: California Hepatitis A Outbreak Continues
FDA Approves First-Line Non-Small Cell Lung Cancer Drug
Alectinib (Alecensa) found to significantly improve progression-free survival among patients with lung cancer.
Alectinib Approved as First-Line Lung Cancer Therapy
Alectinib (Alecensa) found to reduce the risk of disease progression in patients with metastatic non-small cell lung cancer.
Amazon May Increase Competition for PBMs
Some pharma executives welcome a disruption to the current pharmacy benefits management system.
Pharmaceutical Manufacturers Stand to Benefit from Amazon Disrupting the Industry
Amazon entering pharmacy may transform pharmacy benefit managers.
Progress Made in Diabetes Screening, Diagnosis
Rigorous screening guidelines can reduce the number of undiagnosed cases of diabetes.
Study: HPV-Linked Throat Cancer Remains Rare
Only 1% of women aged 20 to 68 years had an oral HPV infection.
FDA Approves Zelboraf for Erdheim-Chester Disease
Vemurafenib is a kinase inhibitor indicated to treat patients with Erdheim-Chester disease with BRAF V600 mutations.
FDA Approves First Treatment for Rare Blood Cancer
Vemurafenib (Zelboraf) receives priority review for Erdheim-Chester Disease.
Trending News Today: GOP Considers Individual Mandate Repeal in Tax Reform
Trending News Today: CHIP Funding Bill Approved in the House